| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.054 | 0.09 |